California Life Sciences Association adds six new board members

The California Life Sciences Association (CLSA), an advocacy group, has added six new members to its board of directors.

David Beier is managing director of Bay City Capital and has worked for the firm since 2013. His experience comprises two decades of working on senior management teams for Amgen and Genentech, two of the largest biotech companies in the world.

Ranjeet Banerjee is the worldwide president of Becton, Dickinson’s Medication Management Solutions business unit.

Jane Conoley is the president of California State University. She has also held senior positions at the University of California Santa Barbara, Texas A&M University and University of Nebraska Lincoln.

Ho Sung Cho has been part of Celgene since 2014 and sits on the executive team for the Immuno-oncology Thematic Center of Excellence.

Fritz Bittenbender is senior vice president, government affairs for Genentech. He is a member of Genentech’s US leadership team.

Steve Kay is the director of convergent biosciences, and is a provost professor of neurology, biomedical engineering and biological sciences at the Keck School of Medicine and University of Southern California.